GPC2 deficiency inhibits cell growth and metastasis in colon adenocarcinoma

Glypican-2 (GPC2) has been reported to promote tumor progression through metabolic pathways. However, the role of GPC2 in colon adenocarcinoma (COAD) remains to be further investigated. This study was designed to evaluate the role of GPC2 in COAD. Based on patients with complete clinical information...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lumin, He, Yanbin, Ni, Zhuona, Zhang, Min, Liu, Jie, Mao, Qianqian, Huang, Bin, Lin, Jiumao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847712/
https://www.ncbi.nlm.nih.gov/pubmed/35233466
http://dx.doi.org/10.1515/med-2022-0421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847712/
https://www.ncbi.nlm.nih.gov/pubmed/35233466
http://dx.doi.org/10.1515/med-2022-0421

Ejemplares similares